Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1998 Apr;53(4):292–294. doi: 10.1136/thx.53.4.292

Reduced mortality in association with the acute respiratory distress syndrome (ARDS)

S Abel 1, S Finney 1, S Brett 1, B Keogh 1, C Morgan 1, T Evans 1
PMCID: PMC1745195  PMID: 9741374

Abstract

BACKGROUND—A study was undertaken to investigate possible reductions in mortality and/or changes in outcome predictive factors in patients with the acute respiratory distress syndrome (ARDS) managed in a single centre.
METHODS—The study was a prospective observational cohort study of two patient populations with ARDS. Group 1 comprised 41 patients enrolled between May 1990 and April 1993, and group 2 consisted of 78 patients enrolled between June 1993 and March 1997. The end points of the study were mortality and various factors predictive of death.
RESULTS—There was a marked reduction in mortality between groups 1 and 2 (66% versus 34%; relative risk 1.77; CI 1.23 to 2.55). There were no significant differences between the groups in terms of age (40.6 (3.3) versus 45.5 (2.2) years), APACHE score (14.5 (0.72) versus 13.6 (0.1)), lung injury score (2.95 (0.07) versus 2.8(0.1)), incidence of multi-organ failure (29% versus 32%), incidence of sepsis (31% versus 39%), or PaO2/FIO2 (kPa) ratio (11.8 (0.67) versus 12.0 (0.6)). There was a significantly lower proportion of men in group 1 (51% versus 74%). The case mix of the two groups was closely matched: following elective surgery 48% versus 48%, trauma 17% versus 16%, primary lung injury 12% versus 24%. Patients in group 1 were supported using several ventilatory and other modes (volume preset, non-inverse ratio ventilation, n = 15; pressure controlled inverse ratio ventilation (PC-IRV), n = 11; ultra high frequency jet ventilation (UHFJV), n = 13; an intravascular oxygenation device (IVOX) and extracorporeal gas exchange (ECGE), n = 2). Within group 1 no significant difference in mortality was observed between the patients on volume controlled ventilation and the remainder. In group 2 all patients received PC-IRV (n = 78) but, in addition, some received other support techniques (UHFJV n =4, ECGE n = 2). In group 1 only sepsis on admission (21% (survivors) versus 56% (non-survivors)) predicted death. In group 2 age of survivors and non-survivors (41.2 (2.6) versus 52.6 (3.5)), APACHE score (12.2 (0.6) versus 15.8 (0.9)), and PaO2/FIO2 (12.8 (0.86) versus 10.5 (0.72)) predicted survival, but not the incidence of sepsis or multi-organ failure.
CONCLUSIONS—In recent years a highly significant reduction in mortality associated with ARDS has been observed between two groups of patients well matched for disease severity and case mix. Changes in ICU organisation rather than specific interventions may account for this reduction, although different ventilatory and other management strategies used in the two groups may also be relevant.



Full Text

The Full Text of this article is available as a PDF (86.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amato M. B., Barbas C. S., Medeiros D. M., Schettino G. de P., Lorenzi Filho G., Kairalla R. A., Deheinzelin D., Morais C., Fernandes E. de O., Takagaki T. Y. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1835–1846. doi: 10.1164/ajrccm.152.6.8520744. [DOI] [PubMed] [Google Scholar]
  2. Ashbaugh D. G., Bigelow D. B., Petty T. L., Levine B. E. Acute respiratory distress in adults. Lancet. 1967 Aug 12;2(7511):319–323. doi: 10.1016/s0140-6736(67)90168-7. [DOI] [PubMed] [Google Scholar]
  3. Bernard G. R., Artigas A., Brigham K. L., Carlet J., Falke K., Hudson L., Lamy M., Legall J. R., Morris A., Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818–824. doi: 10.1164/ajrccm.149.3.7509706. [DOI] [PubMed] [Google Scholar]
  4. Engleman H. M., Martin S. E., Deary I. J., Douglas N. J. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997 Feb;52(2):114–119. doi: 10.1136/thx.52.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ferring M., Vincent J. L. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J. 1997 Jun;10(6):1297–1300. doi: 10.1183/09031936.97.10061297. [DOI] [PubMed] [Google Scholar]
  6. Gaynes R. P., Solomon S. Improving hospital-acquired infection rates: the CDC experience. Jt Comm J Qual Improv. 1996 Jul;22(7):457–467. doi: 10.1016/s1070-3241(16)30248-6. [DOI] [PubMed] [Google Scholar]
  7. Johns M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540–545. doi: 10.1093/sleep/14.6.540. [DOI] [PubMed] [Google Scholar]
  8. Krafft P., Fridrich P., Pernerstorfer T., Fitzgerald R. D., Koc D., Schneider B., Hammerle A. F., Steltzer H. The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations. Intensive Care Med. 1996 Jun;22(6):519–529. doi: 10.1007/BF01708091. [DOI] [PubMed] [Google Scholar]
  9. Lee J., Turner J. S., Morgan C. J., Keogh B. F., Evans T. W. Adult respiratory distress syndrome: has there been a change in outcome predictive measures? Thorax. 1994 Jun;49(6):596–597. doi: 10.1136/thx.49.6.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Milberg J. A., Davis D. R., Steinberg K. P., Hudson L. D. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA. 1995 Jan 25;273(4):306–309. [PubMed] [Google Scholar]
  11. Montgomery A. B., Stager M. A., Carrico C. J., Hudson L. D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):485–489. doi: 10.1164/arrd.1985.132.3.485. [DOI] [PubMed] [Google Scholar]
  12. Mortimore I. L., Bradley P. A., Murray J. A., Douglas N. J. Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1759–1762. doi: 10.1164/ajrccm.154.6.8970367. [DOI] [PubMed] [Google Scholar]
  13. Murray J. F., Matthay M. A., Luce J. M., Flick M. R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720–723. doi: 10.1164/ajrccm/138.3.720. [DOI] [PubMed] [Google Scholar]
  14. Prosise G. L., Berry R. B. Oral-nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest. 1994 Jul;106(1):180–186. doi: 10.1378/chest.106.1.180. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES